Discontinuation report TEVA-NYSTATIN
Report ID | 63949 |
Drug Identification Number | 02194201 |
Brand name | TEVA-NYSTATIN |
Common or Proper name | NYSTATIN |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | NYSTATIN |
Strength(s) | 100000UNIT |
Dosage form(s) | SUSPENSION |
Route of administration | ORAL |
Packaging size | 48ML |
ATC code | A07AA |
ATC description | INTESTINALANTIINFECTIVES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2018-06-30 |
Remaining supply date | 2018-07-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | 100ML & 1L Active |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2018-10-12 | French | Compare |
v1 | 2018-10-12 | English | Compare |
Showing 1 to 2 of 2